Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes

BACKGROUND: Mediator complex (MED) proteins have a key role in transcriptional regulation, some interacting with the oestrogen receptor (ER). Interrogation of the METABRIC cohort suggested that MED7 may regulate lymphovascular invasion (LVI). Thus MED7 expression was assessed in large breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Joseph, Chitra, Macnamara, Olivia, Craze, Madeleine, Russell, Roslin, Provenzano, Elena, Nolan, Christopher C., Diez-Rodriguez, Maria, Sonbul, Sultan N., Aleskandarany, Mohammed A., Green, Andrew R., Rakha, Emad A., Ellis, Ian O., Mukherjee, Abhik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931067/
https://www.ncbi.nlm.nih.gov/pubmed/29588513
http://dx.doi.org/10.1038/s41416-018-0041-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931067/
https://www.ncbi.nlm.nih.gov/pubmed/29588513
http://dx.doi.org/10.1038/s41416-018-0041-x

Ejemplares similares